The U.S. Supreme Court is expected to issue a ruling in July 2026 on whether Americans can continue filing lawsuits against pesticide and herbicide manufacturers over allegations that certain products caused cancer. The case, involving Monsanto and its parent company Bayer, was argued before the Court in April, and the outcome could have major consequences for farmers, agricultural input suppliers, and the broader U.S. agricultural economy.

Research examining pesticide use across the United States has intensified scrutiny of the industry's most widely used products. Analyses of federal data indicate that among the 500 counties with the highest pesticide use per square mile, approximately 60% report cancer rates above the national average of 460 cases per 100,000 residents. Many of these counties are located in major agricultural regions producing corn, soybeans, fruits, and vegetables, including states such as Iowa, Illinois, Missouri, California, and Florida.

Bioinputs

Tank Mix Compatibility Emerges as a New Challenge for Biological and Chemical Crop Protection Programs

A study published in 2024 suggested that the impact of pesticide exposure on cancer incidence may be comparable to other major public health risks, fueling ongoing debate among regulators, scientists, and industry stakeholders.

The legal controversy is not new. Bayer has already paid more than $12 billion in settlements related to Roundup litigation, one of the largest product liability cases in U.S. history. According to company figures, more than 65,000 lawsuits have been filed by farmers, landscapers, gardeners, and other users who claim exposure to glyphosate-containing products contributed to cancer diagnoses.

Several jury verdicts have resulted in substantial awards, including multimillion-dollar judgments that have increased pressure on the agrichemical sector and raised concerns among investors.

Facing continued litigation, pesticide manufacturers have intensified lobbying efforts in state legislatures to secure what critics call "liability shields." These measures would largely prevent state-level lawsuits when products comply with labeling approved by the Environmental Protection Agency (EPA). Supporters argue that allowing lawsuits despite federal approval creates legal uncertainty and threatens access to essential crop protection tools.

So far, only Georgia and North Dakota have enacted such protections, but similar proposals continue to emerge in other agricultural states.

The issue has also become politically charged. While environmental groups and some public health advocates have pushed for stricter oversight of pesticides, the Trump administration has largely defended existing EPA regulatory standards.

Earlier concerns raised about pesticide exposure and childhood health impacts were softened in subsequent federal reviews, which instead emphasized confidence in current regulatory frameworks.

In another significant move, President Trump signed an executive order describing glyphosate as strategically important to U.S. national interests, highlighting the chemical's role in maintaining agricultural productivity and food security.

For producers, the case extends beyond legal theory.

Glyphosate remains one of the most widely used weed-control tools in American agriculture, particularly in corn and soybean production. Any legal precedent that increases liability exposure for manufacturers could influence input costs, product availability, crop protection strategies, and long-term investment in agricultural innovation.

Industry groups warn that limiting legal protections could discourage future development of crop protection technologies. Critics counter that consumers and farm workers deserve access to legal remedies when safety concerns emerge.

At the center of the case, Monsanto v. Durnell, Bayer argues that federal law should override state-level claims because the EPA has repeatedly concluded that glyphosate is unlikely to cause cancer. Opponents maintain that states should retain authority to allow juries to evaluate evidence and award damages when appropriate.

The Supreme Court's decision, expected in July, could establish a nationwide precedent affecting thousands of pending and future cases.